These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HDL cholesterol and atherosclerosis. Mazzone T Lancet; 2007 Jul; 370(9582):107-108. PubMed ID: 17630020 [No Abstract] [Full Text] [Related]
6. Atorvastatin and glatiramer acetate: new hope in MS? Bradbury J Lancet Neurol; 2006 May; 5(5):386-7. PubMed ID: 16639832 [No Abstract] [Full Text] [Related]
7. Effect of atorvastatin on plasma fibrinogen. Wierzbicki AS; Lumb PJ; Semra YK; Crook MA Lancet; 1998 Feb; 351(9102):569-70. PubMed ID: 9492781 [No Abstract] [Full Text] [Related]
8. Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve. Makkena B; Salti H; Subramaniam M; Thennapan S; Bonow RH; Caira F; Bonow RO; Spelsberg TC; Rajamannan NM J Am Coll Cardiol; 2005 Feb; 45(4):631-3. PubMed ID: 15708716 [No Abstract] [Full Text] [Related]
9. Atorvastatin: in the management of hyperlipidaemia. Ray SK; Rege NN J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482 [No Abstract] [Full Text] [Related]
10. Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets. Kappelle PJ; Dallinga-Thie GM; Dullaart RP; Biochim Biophys Acta; 2010 Jan; 1801(1):89-94. PubMed ID: 19800983 [TBL] [Abstract][Full Text] [Related]
11. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin. Li M; Xu A; Lam KS; Cheung BM; Tse HF Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455 [TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension. Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related]
14. Liptruzet: a combination of ezetimibe and atorvastatin. Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796 [No Abstract] [Full Text] [Related]
15. Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin. Trifiletti A; Lasco A; Scamardi R; Pizzoleo MA; Gaudio A; La Rocca R; Morini E; Frisina N Pathophysiol Haemost Thromb; 2003; 33(2):84-7. PubMed ID: 14624049 [TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibitors and renal function. Campese VM; Park J Clin J Am Soc Nephrol; 2007 Nov; 2(6):1100-3. PubMed ID: 17942762 [No Abstract] [Full Text] [Related]
17. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607 [TBL] [Abstract][Full Text] [Related]
20. Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats. Heeba GH; Abd-Elghany MI Phytomedicine; 2010 Dec; 17(14):1076-81. PubMed ID: 20576411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]